Achaogen, Inc. $100.9 Million Follow-On Offering

Davis Polk advised the joint book-running managers in connection with the $100.9 million public offering of common stock of Achaogen, Inc. The common stock is listed onthe NASDAQ Global Market under the symbol “AKAO.”

Leerink Partners, Stifel and Guggenheim Securities acted as Joint Book-Running Managers.

Based in South San Francisco, California, Achaogen, Inc. is a clinical-stage biopharmaceutical company developing novel antibacterials to treat multi-drug resistant gram-negative infections.

The Davis Polk corporate team included partner Bruce K. Dallas (Picture) and associates Jeffrey C. Lau and Leeann Saw. The tax team included partner Rachel D. Kleinberg and associate Samantha Jacoby. The intellectual property and technology team included counsel Michelle Ontiveros Gross and associate Jason J. Bang. Counsel Marcie A. Goldstein provided FINRA advice.

Involved fees earner: Bruce Dallas – Davis Polk & Wardwell; Jeffrey Lau – Davis Polk & Wardwell; Rachel Kleinberg – Davis Polk & Wardwell; Samantha Jacoby – Davis Polk & Wardwell; Michelle Ontiveros Gross – Davis Polk & Wardwell; Jason Bang – Davis Polk & Wardwell; Marcie Goldstein – Davis Polk & Wardwell;

Law Firms: Davis Polk & Wardwell;

Clients: Stifel Financial Corp.; Guggenheim partners LLC; Leerink Partners;


Author: Ambrogio Visconti